Question 1

Does Point72 Asset Management own RLAY stock?

Accepted Answer

No. Point72 Asset Management exited its RLAY (Relay Therapeutics) position in Q1 2026. Its Q4 2025 13F listed 13,859,172 shares worth $117.2M.

Question 2

How many shares of RLAY does Point72 Asset Management own?

Accepted Answer

None since Q1 2026, when Point72 Asset Management exited the position. Its Q4 2025 13F listed 13,859,172 shares worth $117.2M.

Question 3

What is Point72 Asset Management's RLAY position worth?

Accepted Answer

Point72 Asset Management's RLAY position was worth $117.2M in its Q4 2025 13F, before the exit in Q1 2026.

Question 4

Is Point72 Asset Management buying or selling RLAY?

Accepted Answer

In Q1 2026, Point72 Asset Management exited its entire RLAY position.

Question 5

When did Point72 Asset Management first buy RLAY?

Accepted Answer

Point72 Asset Management first reported RLAY in its Q2 2023 13F and listed it in 9 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q1 Latest	Exited	0	-100.0%	$0	0.0%	$9.85	0
2025-Q4	Decreased	13.9M	-6.2%	$117.2M	0.1%	$8.35	0
2025-Q3	Increased	14.8M	+9.9%	$77.1M	0.1%	$5.19	39
2025-Q2	Increased	13.4M	+24.2%	$46.5M	0.1%	$3.30	36
2025-Q1	Increased	10.8M	+579.8%	$28.4M	0.1%	$2.72	46
2024-Q4	Increased	1.6M	+18.0%	$6.6M	0.0%	$4.18	32
2024-Q3	New	1.3M	—	$9.6M	0.0%	$7.46	38